-----BEGIN PRIVACY-ENHANCED MESSAGE-----
Proc-Type: 2001,MIC-CLEAR
Originator-Name: webmaster@www.sec.gov
Originator-Key-Asymmetric:
 MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen
 TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB
MIC-Info: RSA-MD5,RSA,
 AEl2qjx4D7otdN7875O8e2B4PtklOqc+WYvgqB6gAYQhHcZptRiJ826L+rCrDD/k
 BnCsQ0ovzCdUq81OC4Sc9w==

<SEC-DOCUMENT>0000069499-03-000031.txt : 20030515
<SEC-HEADER>0000069499-03-000031.hdr.sgml : 20030515
<ACCEPTANCE-DATETIME>20030515140230
ACCESSION NUMBER:		0000069499-03-000031
CONFORMED SUBMISSION TYPE:	4
PUBLIC DOCUMENT COUNT:		1
CONFORMED PERIOD OF REPORT:	20021121
FILED AS OF DATE:		20030515

ISSUER:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			MYLAN LABORATORIES INC
		CENTRAL INDEX KEY:			0000069499
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				251211621
		STATE OF INCORPORATION:			PA
		FISCAL YEAR END:			0331

	BUSINESS ADDRESS:	
		STREET 1:		1500 CORPORATE DRIVE
		STREET 2:		SUITE 400
		CITY:			CANONSBURG
		STATE:			PA
		ZIP:			15317
		BUSINESS PHONE:		724-514-1800

	MAIL ADDRESS:	
		STREET 1:		1500 CORPORATE DRIVE
		STREET 2:		SUITE 400
		CITY:			CANONSBURG
		STATE:			PA
		ZIP:			15317

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	FRM CORP
		DATE OF NAME CHANGE:	19711003

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			GAISFORD JOHN C DR
		CENTRAL INDEX KEY:			0001114100

	FILING VALUES:
		FORM TYPE:		4
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-09114
		FILM NUMBER:		03703403

	BUSINESS ADDRESS:	
		STREET 1:		SUITE 340
		STREET 2:		MELLON PAVILION
		CITY:			PITTSBURGH
		STATE:			PA
		ZIP:			15224
		BUSINESS PHONE:		4126815266

	MAIL ADDRESS:	
		STREET 1:		SUITE 340 MELLON PAVILION
		CITY:			PITTSBURGH
		STATE:			PA
		ZIP:			15224
</SEC-HEADER>
<DOCUMENT>
<TYPE>4
<SEQUENCE>1
<FILENAME>primary_doc.xml
<DESCRIPTION>PRIMARY DOCUMENT
<TEXT>
<XML>
<?xml version="1.0"?>

<ownershipDocument>

    <documentType>4</documentType>

    <periodOfReport>2002-11-21</periodOfReport>


    <notSubjectToSection16>0</notSubjectToSection16>

    <issuer>
        <issuerCik>0000069499</issuerCik>
        <issuerName>MYLAN LABORATORIES INC</issuerName>
        <issuerTradingSymbol>MYL</issuerTradingSymbol>
    </issuer>

    <reportingOwner>
        <reportingOwnerId>
            <rptOwnerCik>0001114100</rptOwnerCik>
            <rptOwnerName>GAISFORD JOHN C DR</rptOwnerName>
        </reportingOwnerId>
        <reportingOwnerAddress>
            <rptOwnerStreet1>  </rptOwnerStreet1>
            <rptOwnerStreet2>  </rptOwnerStreet2>
            <rptOwnerCity>  </rptOwnerCity>
            <rptOwnerState>  </rptOwnerState>
            <rptOwnerZipCode>  </rptOwnerZipCode>
        </reportingOwnerAddress>
        <reportingOwnerRelationship>
            <isDirector>1</isDirector>
            <isOfficer>0</isOfficer>
            <isTenPercentOwner>0</isTenPercentOwner>
            <isOther>0</isOther>
        </reportingOwnerRelationship>
    </reportingOwner>

    <nonDerivativeSecurity>
        <securityTitle>
            <value>Mylan Laboratories Inc. Common Stock</value>
            <footnoteId id="F1"/>
        </securityTitle>
        <transactionDate>
            <value>2002-11-21</value>
        </transactionDate>
        <transactionCoding>
            <transactionFormType>4</transactionFormType>
            <transactionCode>S</transactionCode>
            <equitySwapInvolved>0</equitySwapInvolved>
        </transactionCoding>
        <transactionTimeliness>
            <value></value>
        </transactionTimeliness>
        <transactionAmounts>
            <transactionShares>
                <value>26</value>
            </transactionShares>
            <transactionValue>
                <value>20.0667</value>
            </transactionValue>
            <transactionAcquiredDisposedCode>
                <value>D</value>
            </transactionAcquiredDisposedCode>
        </transactionAmounts>
        <postTransactionAmounts>
            <sharesOwnedFollowingTransaction>
                <value>576</value>
            </sharesOwnedFollowingTransaction>
        </postTransactionAmounts>
        <ownershipNature>
            <directOrIndirectOwnership>
                <value>I</value>
                <footnoteId id="F2"/>
            </directOrIndirectOwnership>
            <natureOfOwnership>
                <value>By wife in IRA</value>
            </natureOfOwnership>
        </ownershipNature>
    </nonDerivativeSecurity>

    <footnotes>
        <footnote id="F1">This transaction for 26 shares was inadvertently not reported due to an administrative oversight.</footnote>
        <footnote id="F2">Mylan Laboratories Inc. common stock beneficially owned directly total is 10,650.</footnote>
    </footnotes>

    <ownerSignature>
        <signatureName>John C. Gaisford</signatureName>
        <signatureDate>2003-05-15</signatureDate>
    </ownerSignature>

</ownershipDocument>

</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
-----END PRIVACY-ENHANCED MESSAGE-----